PharmaShots | Incisive News in 3 Shots

Subscribe Now

Skyline Therapeutics

Skyline Therapeutics Receives the US FDA’s IND Clearance of SKG0106 for Neovascular Age-related Macular Degeneration

Skyline Therapeutics Receives the US FDA’s IND Clearance of SKG0106 for Neovascular Age-related Macular Degeneration

July 3, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us